Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

Thumbnail

ADHD medications associated with heightened CVD risk

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

Thumbnail

Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes

Novo Nordisk shared initial results from the SELECT trial back in August, but now the full analysis—which includes data from more than 17,000 patients—has been published in The New England Journal of Medicine. 

Rasha Al-Lamee, MBBS, PhD, a cardiologist with the National Heart and Lung Institute in London

PCI benefits patients with stable chest pain, late-breaking data confirm

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said. 

tirzepatide injections Zepbound Eli Lilly

FDA approves diabetes drug tirzepatide for chronic weight management under new name

The FDA issued its own statement about the approval, highlighting the importance of taking the drug in combination with an improved diet and regular physical activity.  

Video of Patrick McGill, MD, explaining how Community Health Network in Indiana eliminated more than 5 million nuisance alerts.

Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

"Changing just six alerts in the system knocked out about 5 million alerts annually," explained Patrick McGill, MD, executive vice president and chief transformation officer at CHN.

private equity corporatization business consolidation

Private equity-backed pharmaceutical company acquires stroke drug from Bayer

The drug, nimodipine, is a second-generation calcium channel blocker designed to prevent and treat cerebral vasospasm following an aneurysmal subarachnoid hemorrhage.

Amazon Pharmacy is now delivering medications by done

Amazon Pharmacy now delivering medications by drone, promising orders in 1 hour or less

The new service is now live in College Station, Texas. The drones use a series of sensors and cameras to remain stable and navigate around obstacles as needed.